Cardiovascular disease - DiabetesontheNet

Aggressive stance needed in the multifactoral management of CVD risk factors in IGT and IGF as well as diabetes

Retinopathy and coronary heart disease risk

Meeting Report: 43rd Annual Meeting of the European Association for the Study of Diabetes

Cardiac risk stratification in people with asymptomatic diabetes

PROactive stroke data is encouraging, but must be used with care

An interim analysis of rosiglitazone evaluated for cardiovascular outcomes: The RECORD study group

Coronary artery calcium scoring: Does it add anything?

Rosiglitazone and the thiazolidinediones: The trials of doing trials

Optimising the care of patients with type 2 diabetes and cardiovascular disease

Meeting reports: 67th Scientific Sessions of the American Diabetes Association

The Khush Dil project: Raising CHD awareness in the South Asian community

Lipid lowering: Known knowns and known unknowns

Defining the role of lipid-lowering therapy in diabetes

Cardiovascular event reduction in high-risk patients

Do guidelines impact upon clinical results?

OGTT is needed for appropriate classification of glucose regulation in patients with CAD

Glycaemic durability of rosiglitazone, metformin or glibenclamide monotherapy

Moving forward with glitazones?